:::::::::: 글로벌번역통역센터 ::::::::::
 
 



 
 
> 고객지원센터 > News & Notice
ADMIN 2021. 12. 02.  
LIST  MODIFY  DELETE  WRITE  REPLY 
   제목: Celltrion's founder Seo officially walks away


Celltrion's founder Seo officially walks away

Seo's retirement came 19 years after he established Celltrion, which is now Korea’s 10th largest company by market cap.

Seo’s vacancy at Celltrion Group is being filled by his two sons, who are in their mid-30s. Seo Jin-seok, currently vice president at Celltrion and head of the company’s product development team, joined the boards of both Celltrion and Celltrion Pharm on Friday. Seo's official title within the company will remain unchanged as vice president but he will take over his father's role as chairman of Celltrion's board.

Seo Joon-seok, a Celltrion executive in operation support, was appointed executive director at Celltrion Healthcare.

Their appointments were approved by shareholders at the companies’ annual general meetings on Friday.

“Seo Jin-seok is joining the board in my place but the company’s management will be led by business professionals,” the former chairman told shareholders during the meeting. “Dividing ownership and management may not be the ultimate answer but my goal is to realize a model close to it as possible."

Management of the Celltrion Group will be headed by Vice Chairs Kee Woo-sung and Kim Hyoung-ki, respectively chief executives of Celltrion and Celltrion Healthcare, a spokesman added.

The elder Seo will hold on to the title “honorary chairman” but will not be engaged in Celltrion’s business anymore.

The founder promised to retire last year, saying the successful launch of the Covid-19 treatment regdanvimab would be his last project. Regdanvimab, which goes by the product name Regkirona, received conditional use approval from Korea’s drug regulators on Feb. 5 and is currently in use as an official treatment at local hospitals.

Seo told reporters last year he planned to establish another start-up in the healthcare industry after retirement.

Seo founded Celltrion in 2002. In less than two decades, Celltrion has grown to a company with market capitalization of 42.4 trillion won as of Friday.

Originally known for bio similar products, the company saw its value soar during the Covid-19 pandemic as a domestic leader in the race to develop a coranavirus treatment.

Regdanvimab is undergoing reviews for use in Europe. Seo told shareholders that the European Medicines Agency will likely announce results before Saturday morning.

“We’re currently discussing exports with seven countries,” he said, adding that if all goes well, the treatment will be sold at around 85 percent the price of competing products.

BY SONG KYOUNG-SON

Excerpts articles from Korea Joongang Daily
LIST  MODIFY  DELETE  WRITE  REPLY 





전체글 목록 2021. 12. 02.  전체글: 954  방문수: 2936054
 공지  정규직,계약직,프리랜서직 모집 
832   How Climate Policy Will Change in 2021
831   World-Dominating Superstar Firms Get Bigger, Techier, and More Chinese 
830   Bottom Drops Out of the Red-Hot Market for Electric Vehicle Start-Ups 
829   GS Retail eyes new acquisition to bolster online business
828   BioNTech to Build Covid-19 Vaccine Facility in Singapore By 2023
827   The Lithium Gold Rush: Inside the Race to Power Electric Vehicles
826   Warren Buffett Wants to Make You Happier, Smarter and Richer 
825   Europe's economy is expected to shrink while the U.S.뭩 grows. 
824   Tesla Makes Money (Including From Selling Cars) 
823   Slow vaccination may hamper economic recovery 
822   Korea to strengthen monitoring of cryptocurrencies 
821   JPMorgan Warns of Bitcoin Weakness as Futures Get Liquidated 
820   SK Telecom launches 5G-based disinfection robot 
819   Citibank to exit retail banking in 13 markets including Korea 
818   Archegos Ripples Through Banks Lucrative Hedge Fund Units 
817   Union Loss May Bring New Phase of Campaign Against Amazon 
816   IMF revises up Korea's GDP growth forecast to 3.6% on robust exports 
815   A K-Shaped Recovery, This Time on a Global Scale 
814   Upbit operator Dunamu expected to go public on NYSE 
813   Technology After the Pandemic 
812   Will Samsung Electronics post earnings surprise in Q1? 
811   Banks Face Billions in Losses as a Bet on ViacomCBS and Other Stocks Goes Awry 
810   Celltrion's founder Seo officially walks away 
809   JPMorgan, Binance still tapped as potential buyers of Bithumb 
808   Market value of cryptocurrencies in Korea spikes tenfold over 3 years 
807   China뭩 Jaded Techies Find a Hero in Elon Musk 
806   First Day of Trading as Gaming Booms 
805   Tax hikes set to be on table amid rising debts 
804   Lessons From a Year of Pandemic Spending 
803   State-run organizations to strengthen ESG values 
RELOAD VIEW DEL WRITE
[1] [2] [3] 4 [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 32